{"product_id":"9th-annual-msk-symposium-on-lymphoma","title":"9th Annual MSK Symposium on Lymphoma (Videos with subtitles + Slides)","description":"\u003ch3\u003e9th Annual MSK Symposium on Lymphoma\u003c\/h3\u003e\n\u003ch3 class=\"activitysectionbold\"\u003eSpecialties\u003c\/h3\u003e\n\u003cem\u003eSpecialties \u003c\/em\u003e- Anatomic Pathology, Bone Marrow Transplant, Cellular Therapeutics, Clinical Pathology, Geriatric Medicine, Hematology, Hematopathology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Molecular Pathology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology\u003cbr\u003e\u003ch3 class=\"activitysectionbold\"\u003eOverview\u003c\/h3\u003e\u003cbr\u003eThis annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking drug developments that are redefining patient care. Attendees will gain valuable insights into the latest findings in lymphoma biology and pathology, exploring how these breakthroughs are being translated into practical, impactful solutions for clinical practice.\u003cbr\u003e\u003cbr\u003eThis year's program, spanning a day and a half, features:\u003cbr\u003e\u003cbr\u003e— \u003cstrong\u003eKeynote Lectures:\u003c\/strong\u003e Featuring renowned leaders in lymphoma research and care.\u003cbr\u003e— \u003cstrong\u003eInteractive Panel Discussions: \u003c\/strong\u003ePractical discussions on innovative approaches to advancing patient outcomes.\u003cbr\u003e— \u003cstrong\u003eEmpowering APPs and Nurses: Professional Development Breakout Session (In-Person Only):\u003c\/strong\u003e Tailored content for interprofessional teams, emphasizing their pivotal role in advancing lymphoma treatment. This breakout session will held on the afternoon of Friday, April 25.\u003cbr\u003e— \u003cstrong\u003eNetworking Opportunities (In-Person Only): \u003c\/strong\u003eConnect with colleagues and faculty during breaks as well as a dedicated Welcome Reception on the evening of Friday, April 25, and a Farewell Lunch Reception on Saturday, April 26. Please RSVP during registration if you plan to attend either reception.\u003cbr\u003e\u003cbr\u003eAdditionally, attendees will gain access to an online syllabus following the symposium, which will include select PDFs of faculty presentations (slides) and recorded videos. Please note, if you are unable to attend the Nursing and APP Breakout Session in person, it will be recorded and made available through the syllabus after the event.\u003cbr\u003e\u003cbr\u003eThe target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the choice of attending either in-person or virtually.\u003cbr\u003e\u003cbr\u003eWe look forward to welcoming colleagues and esteemed faculty from around the world to exchange insights and advance the future of lymphoma care.\u003cbr\u003e\u003ch3 class=\"activitysectionbold\"\u003eObjectives\u003c\/h3\u003e\u003cbr\u003eAt the conclusion of this symposium, attendees will be able to:\u003cbr\u003e\u003col\u003e\n\u003cli\u003eDescribe recent advances in lymphoma classification\u003c\/li\u003e\n\u003cli\u003eDiscuss first line treatment options in most frequent lymphoma entities\u003c\/li\u003e\n\u003cli\u003eDescribe new agents mode of actions, efficacy, side effects\u003c\/li\u003e\n\u003cli\u003eDiscuss options and recommendations for patients in the relapse refractory setting\u003c\/li\u003e\n\u003cli\u003eProvide adequate information to help shared decision with patients regarding their treatment\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eSchedule\u003c\/h3\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eFriday, April 25, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRelevant Financial Relationships\u003c\/strong\u003e\u003cbr\u003e7:00AM - 7:10AM\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEpidemiology and Outcomes of Lymphoma\u003c\/strong\u003e\u003cbr\u003e8:05AM - 9:05AM\u003cbr\u003eChristopher Flowers, MD, MS, FASCO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTreatment Initiation Versus Active Surveillance\u003c\/strong\u003e\u003cbr\u003e9:05AM - 9:35AM\u003cbr\u003eBrian Link, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHistologic Transformation of Follicular Lymphoma\u003c\/strong\u003e\u003cbr\u003e9:35AM - 10:05AM\u003cbr\u003eClementine Sarkozy, MD, PhD, Doctor\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNew Drugs on the Horizon for Follicular Lymphoma\u003c\/strong\u003e\u003cbr\u003e10:05AM - 10:25AM\u003cbr\u003eAndrew D Zelenetz, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Current Challenges in the Management of Patients with Follicular Lymphoma\u003c\/strong\u003e\u003cbr\u003e10:25AM - 10:45AM\u003cbr\u003eEfrat Luttwak, MD (Moderator)\u003cbr\u003eGilles Salles, MD, PhD (Moderator)\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRecent Insights Into Mantle Cell Lymphoma Biology\u003c\/strong\u003e\u003cbr\u003e11:00AM - 11:15AM\u003cbr\u003eShenon Sethi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Dilemma in the First Line Therapy Setting\u003c\/strong\u003e\u003cbr\u003e11:15AM - 11:45AM\u003cbr\u003eKami Maddocks, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCellular Therapies for Treating Mantle Cell Lymphoma\u003c\/strong\u003e\u003cbr\u003e11:45AM - 12:00PM\u003cbr\u003eZachary D Epstein-Peterson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Advances in Therapeutic Strategies for Mantle Cell Lymphoma\u003c\/strong\u003e\u003cbr\u003e12:00PM - 12:20PM\u003cbr\u003eAhmet Dogan, MD, PhD (Moderator)\u003cbr\u003eAnita Kumar, MD (Moderator)\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBiology of Hodgkin Lymphoma\u003c\/strong\u003e\u003cbr\u003e1:20PM - 2:05PM\u003cbr\u003eMargaret Shipp, MDPlease note the PDF version of this presentation is a edited version.\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThe Evolving Standard of Care in First Line\u003c\/strong\u003e\u003cbr\u003e2:05PM - 2:25PM\u003cbr\u003eRobert Stuver, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManagement of Older Patients\u003c\/strong\u003e\u003cbr\u003e2:25PM - 2:45PM\u003cbr\u003eSarah C. Rutherford, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOptions After First Line Treatment Failure\u003c\/strong\u003e\u003cbr\u003e2:45PM - 3:05PM\u003cbr\u003eAlison Moskowitz, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Hodgkin Lymphoma\u003c\/strong\u003e\u003cbr\u003e3:05PM - 3:25PM\u003cbr\u003eAlison Moskowitz, MD (Moderator)\u003cbr\u003eRaphael E Steiner , MD (Moderator)\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGerminal Center Biology\u003c\/strong\u003e\u003cbr\u003e3:40PM - 4:10PM\u003cbr\u003eLaura Pasqualucci, MDOnly a PDF of this presentation will be provided.\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003cstrong\u003eB-Cell Dynamics in the Germinal Center\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e4:10PM - 4:40PM\u003cbr\u003eCoraline Mlynarczyk, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNotch and Marginal Zone Biology\u003c\/strong\u003e\u003cbr\u003e4:40PM - 5:10PM\u003cbr\u003eIvan Maillard, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSingle Cell Analysis of B-Cell Lymphoma\u003c\/strong\u003e\u003cbr\u003e5:10PM - 5:40PM\u003cbr\u003eSandrine Roulland, PharmD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: The Dark Side of B-Cells\u003c\/strong\u003e\u003cbr\u003e5:40PM - 6:10PM\u003cbr\u003eSean E Healton, MD, PhD (Moderator)\u003cbr\u003eAndrew Intlekofer, MD (Moderator)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eSaturday, April 26, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAdvances in Biology\u003c\/strong\u003e\u003cbr\u003e8:05AM - 8:20AM\u003cbr\u003eTing Zhou, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOptimizing First Line Therapy\u003c\/strong\u003e\u003cbr\u003e8:20AM - 8:50AM\u003cbr\u003eBarbara Pro, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAdvancing Therapeutic Options in the Relapse Setting\u003c\/strong\u003e\u003cbr\u003e8:50AM - 9:10AM\u003cbr\u003eJasmine Zain, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Improving Outcomes of Patients with T-Cell Lymphoma\u003c\/strong\u003e\u003cbr\u003e9:10AM - 9:30AM\u003cbr\u003eZachary D Epstein-Peterson, MD (Moderator)\u003cbr\u003eSteven Horwitz, MD (Moderator)\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eProgress in Large B-Cell Lymphoma Management\u003c\/strong\u003e\u003cbr\u003e9:45AM - 10:15AM\u003cbr\u003eGeorg Lenz, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003cstrong\u003eNew Antibodies Engaging Immune Cells\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e10:15AM - 10:35AM\u003cbr\u003eLorenzo Falchi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate on Primary Mediastinal B-Cell Lymphoma\u003c\/strong\u003e\u003cbr\u003e10:35AM - 10:50AM\u003cbr\u003eRaphael E Steiner , MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate on Burkitt Lymphoma\u003c\/strong\u003e\u003cbr\u003e10:50AM - 11:00AM\u003cbr\u003eAriela Noy, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003cstrong\u003ePanel Discussion: Aggressive B-Cell Lymphoma: Addressing Remaining Gaps on the Path to a Definitive Cure\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e11:00AM - 11:05AM\u003cbr\u003ePaul A Hamlin, MD (Moderator)\u003cbr\u003ePallawi Torka, MD (Moderator)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eOptimizing Patient Selection in 2025\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e11:05AM - 11:25AM\u003cbr\u003eLia Palomba, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRadiation Therapy and CAR T\u003c\/strong\u003e\u003cbr\u003e11:25AM - 11:45AM\u003cbr\u003eBrandon Imber, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLessons and Challenges\u003c\/strong\u003e\u003cbr\u003e11:45AM - 12:30PM\u003cbr\u003eDavid G. Maloney, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Aggressive B-Cell Lymphoma \u0026amp; Car T-Cell Therapies in Large B-Cell Lymphoma\u003c\/strong\u003e\u003cbr\u003e12:30PM - 1:00PM\u003cbr\u003eAlexander Paul Boardman, MD (Moderator)\u003cbr\u003ePaul A Hamlin, MD (Moderator)\u003cbr\u003eGunjan Shah , MD, MS (Moderator)\u003cbr\u003ePallawi Torka, MD (Moderator)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003ch3\u003eBreakout Session: Nursing Professional Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMantle Cell Lymphoma in Ambulatory Setting: Focus on Supportive Care and Adverse Event Management\u003c\/strong\u003e\u003cbr\u003e3:45PM - 4:05PM\u003cbr\u003eLauren Drosick, PA-C\u003cbr\u003eCarissa Laudati\u003cbr\u003eJoanna Mi, MSN|NP\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCAR T-Cell Therapy for B Cell Lymphoma: Approach to Management and Care in the Outpatient Setting\u003c\/strong\u003e\u003cbr\u003e4:05PM - 4:25PM\u003cbr\u003eAshley Ames, FNP-BC, NP\u003cbr\u003eDana Guerra, BSN, RN\u003cbr\u003eEmily Spevack, BSN\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eResearch Spotlight: Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering\u003c\/strong\u003e\u003cbr\u003e4:25PM - 4:50PM\u003cbr\u003eTheresa Davey, PA\u003cbr\u003eMarcel Smith, FNP-BC\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManagement of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma\u003c\/strong\u003e\u003cbr\u003e4:50PM - 5:00PM\u003cbr\u003eAnnalisa Benz, BSN, RN, OCN\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLymphoma Survivorship: Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment\u003c\/strong\u003e\u003cbr\u003e5:00PM - 5:20PM\u003cbr\u003eJennifer Gorelov, NP\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Empowering APPs and Nurses\u003c\/strong\u003e\u003cbr\u003e5:20PM - 5:40PM\u003cbr\u003eLauren Drosick, PA-C (Moderator)\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954494443618,"sku":"MED-AMB04553","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/9th-Annual-MSK-Symposium-on-Lymphoma.webp?v=1779377981","url":"https:\/\/meducourse.com\/products\/9th-annual-msk-symposium-on-lymphoma","provider":"Meducourse","version":"1.0","type":"link"}